Nathan Skene

Has grant

Associate Professor and UK DRI Group Leader

Imperial College London
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Simple questions about neurodegenerative disease: Where? When? What?

Open Date: 2026-02-01

Close Date: 2029-01-01

Grant: Open

Increasing the capabilities of complex epigenetics through effective multiplexing with novel SNAP-Tn5

Open Date: 2025-04-01

Close Date: 2027-03-01

Grant: Close

Using coppaFISH to determine the cell types associated with alpha-synuclein pathology

Open Date: 2025-04-01

Close Date: 2026-11-01

Grant: Close

Manipulating microglia states with transcription factors

Open Date: 2024-10-01

Close Date: 2025-09-01

Grant: Close

Understanding selective vulnerability in Parkinson's disease: a pilot study

Open Date: 2023-09-01

Close Date: 2026-03-01

Articles (22)

Year:

2026

Year:

2026

Year:

2026

Summary MotifPeeker benchmarks epigenomic profiling methods targeting transcription factors (TFs) where no “gold standard” reference exists, using motif enrichment as a key metric. With minimal input, users can analyse their data in a single function and receive an intuitive HTML report. Availability and implementation MotifPeeker is available on Bioconductor (≥ v3.21) at https://bioconductor.org/packages/MotifPeeker. The complete source code is available on GitHub at https://github.com/neurogenomics/MotifPeeker, with full documentation provided at https://neurogenomics.github.io/MotifPeeker. Additionally, the MotifPeeker Docker image is hosted on GitHub at https://github.com/neurogenomics/MotifPeeker/pkgs/container/motifpeeker.

Year:

2026

Motivation Mapping genes across identifier systems and species is a routine but critical step in bioinformatics workflows. Despite its ubiquity, gene mapping is frequently handled using bespoke, ad hoc solutions, increasing duplicated effort and introducing opportunities for error. These issues are exacerbated by the prevalence of non–one-to-one homolog relationships and inconsistent handling of gene identifiers across species and databases, which can compromise downstream analyses and reproducibility. Results We present orthogene , an R/Bioconductor package that simplifies gene mapping within and across hundreds of species. orthogene provides a unified, workflow-oriented framework that integrates automated species and identifier standardization, homolog inference across multiple databases, flexible handling of ambiguous homolog relationships, and transformation of gene lists, tables, and high-dimensional matrices into analysis-ready formats. By abstracting common sources of technical complexity while retaining user control, orthogene enables transparent, reproducible, and scalable gene mapping across a wide range of biological contexts. Availability https://bioconductor.org/packages/orthogene Contact [email protected]

Year:

2026

DNA-protein interactions have traditionally been profiled via chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq). Cleavage Under Targets & Tagmentation (CUT&Tag) is a rapidly expanding technique that enables the profiling of such interactions in situ at high sensitivity. However, thorough evaluation and benchmarking against established ChIP-seq datasets are lacking. Here, we comprehensively benchmarked CUT&Tag for H3K27ac and H3K27me3 against published ChIP-seq profiles from ENCODE in K562 cells. Combining multiple new and published CUT&Tag datasets, there was an average recall of 54% known ENCODE peaks for both histone modifications. We tested peak callers MACS2 and SEACR and identified optimal peak calling parameters. Overall, peaks identified by CUT&Tag represent the strongest ENCODE peaks and show the same functional and biological enrichments as ChIP-seq peaks identified by ENCODE. Our workflow systematically evaluates the merits of methodological adjustments, providing a benchmarking framework for the experimental design and analysis of CUT&Tag studies.

Year:

2025

To understand the complex relationship between histone mark activity and gene expression, recent advances have used in silico predictions based on large-scale machine learning models. However, these approaches have omitted key contributing factors like cell state, histone mark function or distal effects, which impact the relationship, limiting their findings. Moreover, downstream use of these models for new biological insight is lacking. Here, we present the most comprehensive study of this relationship to date – investigating seven histone marks in eleven cell types across a diverse range of cell states. We used convolutional and attention-based models to predict transcription from histone mark activity at promoters and distal regulatory elements. Our work shows that histone mark function, genomic distance and cellular states collectively influence a histone mark’s relationship with transcription. We found that no individual histone mark is consistently the strongest predictor of gene expression across all genomic and cellular contexts. This highlights the need to consider all three factors when determining the effect of histone mark activity on transcriptional state. Furthermore, we conducted in silico histone mark perturbation assays, uncovering functional and disease related loci and highlighting frameworks for the use of chromatin deep learning models to uncover new biological insight.

Year:

2025

Perturbed secretion of insulin and other pancreatic islet hormones is the main cause of type 2 diabetes (T2D). The islets harbor five cell types that are potentially altered differently by T2D. Whole-islet transcriptomics and single-cell RNA-sequencing (scRNAseq) studies have revealed differentially expressed genes without reaching consensus. Here, we demonstrate that further insights into T2D disease mechanisms can be obtained by network-based analysis of scRNAseq data from individual cell types. We developed differential gene coordination network analysis (dGCNA) and analyzed islet SmartSeq2 scRNAseq data from 16 T2D and 16 non-T2D individuals. dGCNA reveals T2D-induced cell type-specific networks of dysregulated genes with remarkable ontological specificity, thus allowing for a comprehensive and unbiased functional classification of genes involved in T2D. In beta cells eleven networks of genes are detected, revealing that mitochondrial electron transport chain, glycolysis, cytoskeleton organization, cell proliferation, unfolded protein response and three networks of beta cell transcription factors are perturbed, whereas exocytosis, lysosomal regulation and insulin translation programs are instead enhanced in T2D. Furthermore, we validated the ability of dGCNA to reveal disease mechanisms and predict the functional context of genes by showing that TMEM176A/B regulates beta cell microfilament organization and that CEPBG is an important regulator of the unfolded protein response. In addition, when comparing beta- and alpha cells, we found substantial differences, reproduced across independent datasets, confirming cell type-specific alterations in T2D. We conclude that analysis of networks of differentially coordinated genes provides detailed insight into cell type-specific gene function and T2D pathophysiology.

Year:

2025

Year:

2025

Craniofacial development gives rise to the complex structures of the face and involves the interplay of diverse cell types. Despite its importance, our understanding of human-specific craniofacial developmental mechanisms and their genetic underpinnings remains limited. Here, we present a comprehensive single-nucleus RNA sequencing (snRNA-seq) atlas of human craniofacial development from craniofacial tissues of 24 embryos that span six key time points during the embryonic period (4–8 post-conception weeks). This resource resolves the transcriptional dynamics of seven major cell types and uncovers distinct major cell types, including muscle progenitors and cranial neural crest cells (CNCCs), as well as dozens of subtypes of ectoderm and mesenchyme. Comparative analyses reveal substantial conservation of major cell types, alongside human biased differences in gene expression programs. CNCCs, which play a crucial role in craniofacial morphogenesis, exhibit the lowest marker gene conservation, underscoring their evolutionary plasticity. Spatial transcriptomics further localizes cell populations, providing a detailed view of their developmental roles and anatomical context. We also link these developmental processes to genetic variation, identifying cell type-specific enrichments for common variants associated with facial morphology and rare variants linked to orofacial clefts. Intriguingly, Neanderthal-introgressed sequences are enriched near genes with biased expression in cartilage and specialized ectodermal subtypes, suggesting their contribution to modern human craniofacial features. This atlas offers unprecedented insights into the cellular and genetic mechanisms shaping the human face, highlighting conserved and distinctly human aspects of craniofacial biology. Our findings illuminate the developmental origins of craniofacial disorders, the genetic basis of facial variation, and the evolutionary legacy of ancient hominins. This work provides a foundational resource for exploring craniofacial biology, with implications for developmental genetics, evolutionary biology, and clinical research into congenital anomalies.

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (45)

Harold Snieder

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

Naomi Wray

University of Queensland

AUSTRALIA
View details

Sang hyuck Lee

King’s College London

UNITED KINGDOM
View details

Gerome Breen

Professor of Psychiatric Genetics

King’s College London

UNITED KINGDOM
View details

Ahmad Al Khleifat

King’s College London

UNITED KINGDOM
View details

Isabelle Francesca Foote

Lecturer in Genomics and Ageing

Queen Mary University of London

UNITED KINGDOM
View details

Andrew McIntosh

Professor of Biological Psychiatry

University of Edinburgh

UNITED KINGDOM
View details

Vasiliki Orgeta

Associate Professor

University College London

UNITED KINGDOM
View details

Juan A. Botía

University College London

UNITED KINGDOM
View details

Matthew Hotopf

South London and Maudsley NHS Foundation Trust

UNITED KINGDOM
View details

Cherie Armour

The Queen's University Belfast

UNITED KINGDOM
View details

Marek Rei

Associate Professor

Imperial College London

UNITED KINGDOM
View details

Alexi Nott

Group Leader, Associate Professor

Imperial College London

UNITED KINGDOM
View details

Brittany Mitchell

Senior Research Fellow

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Alan Murphy

Imperial College London

UNITED KINGDOM
View details

Catharina A. Hartman

-

NETHERLANDS
View details

Mtakai Ngara

Lund University

SWEDEN
View details

Boris Lenhard

Imperial College London

UNITED KINGDOM
View details

Eric Harshfield

Assistant Research Professor

University of Cambridge

UNITED KINGDOM
View details

Evangelos Vassos

Clinical Reader

King’s College London

UNITED KINGDOM
View details

Sarah Marzi

Senior Lecturer

King’s College London

UNITED KINGDOM
View details

James Walters

Director and Clinical Professor

Cardiff University

UNITED KINGDOM
View details

Sarah Medland

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Donald M. Lyall

-

UNITED KINGDOM
View details

David Whiteman

Deputy Director

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Nathalie Kingston

Research Professor

University of Cambridge

UNITED KINGDOM
View details

Valentina Mosienko

Academic , Senior Research Fellow and Proleptic Senior Lecturer

University of Bristol

UNITED KINGDOM
View details

Lena Eliasson

Lund University

SWEDEN
View details

Enda Byrne

Senior Research Fellow

University of Queensland

AUSTRALIA
View details

Rashmi Prasad

Associate Professor

Lund University

SWEDEN
View details

Michela Noseda

Imperial College London

UNITED KINGDOM
View details

Elaine Cowan

Associate Researcher in Diabetes

Lund University

SWEDEN
View details

Ping Chen

Group Leader/Academy Research Fellow

Karolinska Institutet-Huddinge Campus

SWEDEN
View details

Geneviève Morneau-Vaillancourt

Professeure adjointe

Université de Sherbrooke

CANADA
View details

Nicholas Martin

Senior Scientist and Senior Principal Research Fellow

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Conceição Bettencourt

University College London

UNITED KINGDOM
View details

Daniel J Smith

Chair of Psychiatry

University of Edinburgh

UNITED KINGDOM
View details

Elham Assary

King’s College London

UNITED KINGDOM
View details

Ian B. Hickie

Co-Director Health and Policy

University of Sydney

AUSTRALIA
View details

Catherine Olsen

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Jonathan Coleman

Senior Lecturer in Statistical Genetics

King’s College London

UNITED KINGDOM
View details

Thalia Eley

Professor of Developmental Behavioural Genetics

King’s College London

UNITED KINGDOM
View details

Alexandros Karagiannopoulos

Lund University

SWEDEN
View details

Saakshi Kakar

King's College London

UNITED KINGDOM
View details

Magda Bucholc

University of Ulster

UNITED KINGDOM
View details